168 related articles for article (PubMed ID: 12662906)
1. Use of human liver S9 in the Ames test: assay of three procarcinogens using human S9 derived from multiple donors.
Hakura A; Suzuki S; Sawada S; Sugihara T; Hori Y; Uchida K; Kerns WD; Sagami F; Motooka S; Satoh T
Regul Toxicol Pharmacol; 2003 Feb; 37(1):20-7. PubMed ID: 12662906
[TBL] [Abstract][Full Text] [Related]
2. Advantage of the use of human liver S9 in the Ames test.
Hakura A; Suzuki S; Satoh T
Mutat Res; 1999 Jan; 438(1):29-36. PubMed ID: 9858674
[TBL] [Abstract][Full Text] [Related]
3. Salmonella/human S9 mutagenicity test: a collaborative study with 58 compounds.
Hakura A; Shimada H; Nakajima M; Sui H; Kitamoto S; Suzuki S; Satoh T
Mutagenesis; 2005 May; 20(3):217-28. PubMed ID: 15843387
[TBL] [Abstract][Full Text] [Related]
4. Effect of cigarette smoke on the mutagenic activation of various carcinogens in hamster.
Mori Y; Iimura K; Furukawa F; Nishikawa A; Takahashi M; Konishi Y
Mutat Res; 1995 Jan; 346(1):1-8. PubMed ID: 7530323
[TBL] [Abstract][Full Text] [Related]
5. Some factors determining the concentration of liver proteins for optimal mutagenicity of chemicals in the Salmonella/microsome assay.
Malaveille C; Kuroki T; Brun G; Hautefeuille A; Camus AM; Bartsch H
Mutat Res; 1979 Dec; 63(2):245-58. PubMed ID: 392308
[TBL] [Abstract][Full Text] [Related]
6. Difference in liver homogenates from Donryu, Fischer, Sprague-Dawley and Wistar strains of rat in the drug-metabolizing enzyme assay and the Salmonella/hepatic S9 activation test.
Yoshikawa K; Nohmi T; Miyata R; Ishidate M; Ozawa N; Isobe M; Watabe T; Kada T; Kawachi T
Mutat Res; 1982 Oct; 96(2-3):167-86. PubMed ID: 6755239
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of phenobarbital/beta-naphthoflavone as an alternative S9-induction regime to Aroclor 1254 in the rat for use in in vitro genotoxicity assays.
Callander RD; Mackay JM; Clay P; Elcombe CR; Elliott BM
Mutagenesis; 1995 Nov; 10(6):517-22. PubMed ID: 8596471
[TBL] [Abstract][Full Text] [Related]
8. Mutagenic activation of carcinogenic N-nitrosopropylamines by rat liver: evidence for a cytochrome P-450 dependent reaction.
Mori Y; Yamazaki H; Toyoshi K; Makino T; Obara T; Yokose Y; Konishi Y
Carcinogenesis; 1985 Mar; 6(3):415-20. PubMed ID: 3884171
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of pyrazole and ethanol induced S9 fraction in bacterial mutagenicity testing.
Burke DA; Wedd DJ; Herriott D; Bayliss MK; Spalding DJ; Wilcox P
Mutagenesis; 1994 Jan; 9(1):23-9. PubMed ID: 8208127
[TBL] [Abstract][Full Text] [Related]
10. The effects of pretreatment with cytochrome P-450 inducers and preincubation with a cytochrome P-450 effector on the mutagenicity of genotoxic carcinogens mediated by hepatic and renal S9 from two species of marine fish.
Guobaitis RJ; Ellingham TJ; Maddock MB
Mutat Res; 1986 Feb; 164(1):59-70. PubMed ID: 3512989
[TBL] [Abstract][Full Text] [Related]
11. Influence of microsomal and cytosolic fractions from rat, mouse, and hamster liver on the mutagenicity of dimethylnitrosamine in the Salmonella plate incorporation assay.
Prival MJ; Mitchell VD
Cancer Res; 1981 Nov; 41(11 Pt 1):4361-7. PubMed ID: 7030474
[TBL] [Abstract][Full Text] [Related]
12. Suppressed mutagenicity of benzo[a]pyrene by the liver S9 fraction and microsomes from eugenol-treated rats.
Yokota H; Hoshino J; Yuasa A
Mutat Res; 1986 Dec; 172(3):231-6. PubMed ID: 3537779
[TBL] [Abstract][Full Text] [Related]
13. Mutagenic activation of carcinogenic N-nitrosopropylamines by liver S9 fractions from mice, rats and hamsters: evidence for a cytochrome P-450-dependent reaction.
Mori Y; Yamazaki H; Toyoshi K; Denda A; Konishi Y
Carcinogenesis; 1986 Mar; 7(3):375-9. PubMed ID: 3512116
[TBL] [Abstract][Full Text] [Related]
14. Possible mechanisms of antimutagens by various teas as judged by their effects on mutagenesis by 2-amino-3-methylimidazo[4,5-f]quinoline and benzo[a]pyrene.
Chen HY; Yen GC
Mutat Res; 1997 Sep; 393(1-2):115-22. PubMed ID: 9357568
[TBL] [Abstract][Full Text] [Related]
15. Nitrogen-substitution effects on the mutagenicity and cytochrome P450 isoform-selectivity of chrysene analogs.
Yamada K; Hakura A; Kato TA; Mizutani T; Saeki K
Mutat Res; 2005 Sep; 586(1):87-95. PubMed ID: 16087391
[TBL] [Abstract][Full Text] [Related]
16. Expression of human cytochrome P450 1A2 in Escherichia coli: a system for biotransformation and genotoxicity studies of chemical carcinogens.
Kranendonk M; Mesquita P; Laires A; Vermeulen NP; Rueff J
Mutagenesis; 1998 May; 13(3):263-9. PubMed ID: 9643585
[TBL] [Abstract][Full Text] [Related]
17. Is a liver comparable to a liver? A comparison of different rat-derived S9-fractions with a biotechnological animal-free alternative in the Ames fluctuation assay.
Brendt J; Crawford SE; Velki M; Xiao H; Thalmann B; Hollert H; Schiwy A
Sci Total Environ; 2021 Mar; 759():143522. PubMed ID: 33246726
[TBL] [Abstract][Full Text] [Related]
18. Comparative activation of 3,3'-dichlorobenzidine and related benzidines to mutagens in the Salmonella typhimurium assay by hepatic S9 and microsomes from rats pretreated with different inducers of cytochrome P-450.
Iba MM
Mutat Res; 1987 Oct; 182(5):231-41. PubMed ID: 3309638
[TBL] [Abstract][Full Text] [Related]
19. Activation of mutagens by hepatocytes and liver 9000 X g supernatant from human origin in the Salmonella typhimurium mutagenicity assay. Comparison with rat liver preparations.
Neis JM; Yap SH; van Gemert PJ; Roelofs HM; Bos RP; Henderson PT
Mutat Res; 1986 Feb; 164(1):41-51. PubMed ID: 3512987
[TBL] [Abstract][Full Text] [Related]
20. Comparative mutagenicity tests in the Salmonella/microsome assay with rat and woodchuck S9 preparations.
Rashid KA; Babish JG; Johnson BE; Mumma RO
Toxicology; 1985 Aug; 36(2-3):139-46. PubMed ID: 3931301
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
